| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.8 |